Sign Up
Stories
Biotech Leadership Changes and Cancer Immunotherapy
Share
Biotech Advancements in Cancer Treatment
Biotech Firms Advance Cancer Treatment
Biotech and Gene Therapy Appointments an...
12 Million Euros for Cancer Research
AI-Powered Antigen Research Partnership
Advancements in Cancer Treatment and Mar...
Overview
API
Biotechnology companies Anixa Biosciences and ALX Oncology Holdings make significant leadership changes, while CancerVAX, Inc. CEO discusses cancer immunotherapy.
Ask a question
How does the discussion of cancer immunotherapy by CancerVAX, Inc.'s CEO Ryan Davies contribute to the advancements in cancer treatment and research?
How might the establishment of the Cancer Business Advisory Board impact Anixa Biosciences' clinical and business development initiatives?
What are the potential implications of ALX Oncology Holdings' executive leadership realignment on the company's future growth and development?
Article Frequency
0.2
0.4
0.6
0.8
1.0
May 2023
Jun 2023
Jul 2023
Aug 2023
Coverage